Simplify Asset Management has restated the net asset value (NAV) of its Simplify DBi CTA Managed Futures Index ETF (SDMF) for November 2, 2026, lowering it from 27.08 to 26.66 per share, a 1.55% decrease. The adjustment was necessary due to incorrect swap prices previously used in the calculation. This restatement highlights the risks involved with derivative instruments and the importance of accurate pricing in ETF valuations. Investors should review the updated NAV and consider the implications for their portfolios.
The net asset value restatement for Simplify DBi CTA Managed Futures Index ETF (SDMF) provides context for readers. For those following US stocks on Pluang as of Nov 04, 2026 04:02 WIB, out of 150 priced stocks, 78 rose and 71 fell. Notably, Hewlett Packard Enterprise Co (HPE) gained 6.35% to USD 54.41 with a typical hold time of 34 days and a Pluang order activity skewed 70% Sell / 30% Buy, contrasting with Cenovus Energy Inc (CVE) which dropped 6.29% to USD 30.68 over a longer hold time of 47 days, and Block Inc (XYZ) which rose 6.28% to USD 81.92 but saw 100% Sell orders and a typical hold time of 78 days.
Vencora has acquired CT InsureTech, a leading insurance technology provider with offices in London, Buenos Aires, and Mexico City. This acquisition strengthens Vencora's insurance technology offerings and expands its presence in Latin America and Eur...
Vencora has acquired CT InsureTech, a leading provider of insurance technology and services with offices in London, Buenos Aires, and Mexico City. This acquisition expands Vencora's portfolio and presence in Latin America and the UK, strengthening it...
JELD-WEN Holding, Inc. reported a net loss of $17.2 million in Q3 2026, a significant improvement from a $367.6 million loss a year earlier, driven by tariff refunds, productivity gains, and cost reductions. Net revenues slightly declined by 1.4% to ...
Ethereum has achieved end-to-end formal verification of leanVM, a minimal zero-knowledge virtual machine designed to aggregate post-quantum signatures efficiently. This milestone is part of Ethereum's plan to transition its network to quantum-resista...
Viking Therapeutics, a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced its participation in several major healthcare conferences from November to December 2026. The company will engage in fireside chat...
